Results 181 to 190 of about 89,230 (317)
Dual Portal Hypertension in Hepatic Tuberculosis: A Case Report. [PDF]
Joseph A+3 more
europepmc +1 more source
HCV clearance during direct‐acting antiviral therapy rapidly increases serum lipids and lipoproteins, potentially elevating cardiovascular risk. These metabolic changes, mediated by genes regulating hepatic lipogenesis, suggest that lipid levels should be closely monitored post‐SVR to assess long‐term cardiovascular implications.
Zahra Sarrafan‐Chaharsoughi+12 more
wiley +1 more source
3) PATHOPHYSIOLOGY OF IDIOPATHIC PORTAL HYPERTENSION
Haruo KAMEDA, Tadanao Takeda
openalex +2 more sources
Scleroderma and portal hypertension. [PDF]
J Morris, T Htut, Alexandra E. Read
openalex +1 more source
Advances in intrahepatic and extrahepatic vascular dysregulations in cirrhotic portal hypertension. [PDF]
Li Y+8 more
europepmc +1 more source
New‐onset DM occurred in 13% of patients with AIH, was related to older age, non‐Caucasian ethnicity, higher prednisolone dose, higher BMI at diagnosis and weight gain and was an independent predictor of all‐cause death/transplantation and of cirrhosis development, underlining the need to minimise steroid burden in AIH.
Sarah Flatley+6 more
wiley +1 more source
Portal hypertension in children following neonatal umbilical disorders [PDF]
M. Obladen+3 more
openalex +1 more source
A novel noninvasive assessment of portal pressure from computational biofluid mechanics in patients with portal hypertension. [PDF]
Zheng L+13 more
europepmc +1 more source